Brief psychological therapy compared to general practitioners care for depression in primary care: a randomised controlled trial
- Conditions
- DepressionMental and Behavioural DisordersDepressive episode
- Registration Number
- ISRCTN65811640
- Lead Sponsor
- etherlands Organisation for Health Research and Development (ZonMw) (Netherlands)
- Brief Summary
2010 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/20939917 (added 19/09/2019)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 122
Patients aged between 18 and 70 years and suffering from major depressive disorder (MDD) determined by an independent researcher with the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I)
1. Suffering (now and in the past as assessed by the SCID-I) from schizophrenia or bipolar disorder
2. Contra-indication for MDD treatment like mental retardation or terminal illness
3. Having trouble with the Dutch or English language
4. Severe suicidal thoughts
5. Receiving an active MDD treatment. Active treatment is defined as:
5.1. Antidepressive medication (except those who receive this in low dosage for pain complaints: Amitriptyline less than 50 mg, Nortriptyline less than 50 mg, bupropion[Zyban®])
5.2. Psychotherapy
5.3. Supportive visits with the GP or social worker, except for diagnostic visits (less than 2)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> 1. Hamilton depression rating scale-17 by telephone<br> 2. Patient Heath Questionnaire-9: patient rated. Score: 0 (ie, not at all) and 1 (ie, few days) 2 (ie, more than half the days) and 3 (ie, nearly every day)<br><br> All primary outcomes are assessed at baseline, 6, 12 and 52 weeks.<br>
- Secondary Outcome Measures
Name Time Method Medical Outcomes Study 36- Item Short Form Health Survey, assessed at baseline, 12 and 52 weeks.